Announced Fri, 24 Jul, 2026 · 13:19 IST

32nd AGM held via video conferencing; annual accounts adopted with 100% approval

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.0%Reaction day

₹9.08

prior close

₹8.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-2.4% vs market

Commodity Chemicals peers, median of 48sector+0.9%-2.9% vs sector

On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 2.9 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.0+0.4-2.4+0.9-2.9

Next day

-3.9+1.8-5.6+1.9-5.8

-5.3+0.5-5.7+1.5-6.8

-7.6+0.9-8.5+1.6-9.2

-9.4+0.3-9.7+1.6-11.0

-11.1+1.4-12.6+0.9-12.0

-15.3+3.2-18.5+3.8-19.1

15d

-43.5+5.4-48.9+3.0-46.5

-43.8+6.4-50.2+3.0-46.9

-56.3+6.3-62.6+7.4-63.6

-55.7-3.6-52.1-1.6-54.1

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 48Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Kobo Biotech held its 32nd AGM on July 24, 2026 via video conferencing. Only 41 public shareholders attended, representing 19,794 shares (0.08% of capital). The sole resolution to adopt annual accounts for FY ending March 2025 was passed with 100% approval (17,875 votes in favor, none against). The meeting was conducted by Resolution Professional Namrata Randeri, confirming the company remains under CIRP insolvency proceedings.

Likely market impact

Routine procedural filing. Company still under insolvency (CIRP). Extremely low shareholder turnout signals weak investor engagement.